fda approved semaglutide for weight loss approves higher dose of Wegovy to increase patient FBI warns about counterfeit weight

Manufacturer assistance programs often provide discounts for patients who meet income criteria or face insurance gaps

Provide support to social workers, counselors, clergy, or others as needed

The GLP-1 Craze and Laziness: A Cautionary Conversation | Kansas City Laser-Like Lipo July 16, 2025 The GLP-1 Craze: A Cautionary Conversation | Kansas City Laser-Like Lipo Photo Credit: Shutterstock At Kansas City Laser-Like Lipo, we've noticed that over 14 million Americans currently use GLP-1 weight-loss injections like Ozempic, Wegovy, and Mounjaro

Gradual dose reduction may be considered in some circumstances, though this is not universally necessary

Kim S-H, Oh J-M, Kim Y-S, et al

Current guidelines tend to prioritize starting a GLP-1 medication for people who already have cardiovascular or kidney disease, or for those where weight management is a concern